Content on Cancer.Net is approved by the Cancer.Net Editorial Board, composed of over 200 medical, surgical, radiation, and pediatric oncologists, oncology nurses, physician assistants, social workers, and patient advocates.
The Cancer.Net Editors Meeting was held on October 17, 2023 and editors joined both virtually and in person. Editor in Chief Jyoti D. Patel, MD, FASCO, and the site’s Associate Editors reviewed additions and updates to Cancer.Net over the past year, set the 2024 goals for ASCO’s patient education program, and provided expert guidance to ensure that Cancer.Net’s content is comprehensive, credible, current, and accessible for people with cancer.
From top left is Norah Lynn Henry, MD, PhD, FASCO (Breast Cancer), Daniel Mulrooney, MD, MS (Pediatric Cancers). Second row is Vicki Keedy, MD, FASCO (Sarcoma), Third row, from left, is Fay Hlubocky, PhD, MA, FASCO (Psychosocial Oncology), Matthew Yurgelun, MD, FASCO (Gastrointestinal (GI) Cancers). Fourth row is Richard Lee, MD, FASCO (Palliative Care). Fifth row, from left, is Jyoti Patel, MD, FASCO (Editor in Chief), Charu Aggarwal, MD, MPH , FASCO (Lung Cancer).
Not Pictured: Andrew Artz, MD, MS (Leukemia), Lan Coffman, MD, PhD (Gynecologic Cancers), Christopher Flowers, MD, FASCO (Lymphoma), Petros Grivas, MD, PhD (Genitourinary (GU) Cancers), Sagar Lonial, MD, FACP (Myeloma), Manali Patel, MD, MPH, MS, FASCO (Health Equity), Cristina Rodriguez, MD (Head and Neck Cancers), Roy Strowd, III, MD, MEd, MS (Central Nervous System Tumors), and Katy Tsai, MD (Melanoma and Skin Cancers).
View more information about Cancer.Net’s Associate Editors, who lead the Cancer.Net Editorial Board.
View more information about Cancer.Net’s Specialty Editors, who provide topic-specific expertise as part of the Cancer.Net Editorial Board.
View a listing of Cancer.Net’s full advisory panel, which reviews content as part of the Cancer.Net Editorial Board.